Insufficient scRNA-seq data for expression of ANXA2P2 at single-cell level.
Insufficient scRNA-seq data for expression of ANXA2P2 at tissue level.
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
---|---|---|---|---|---|---|
lung | 100% | 238.20 | 576 / 578 | 97% | 40.59 | 1120 / 1155 |
breast | 99% | 192.36 | 455 / 459 | 96% | 22.52 | 1069 / 1118 |
skin | 100% | 395.37 | 1809 / 1809 | 92% | 24.61 | 436 / 472 |
esophagus | 91% | 208.72 | 1309 / 1445 | 100% | 56.59 | 183 / 183 |
intestine | 84% | 87.57 | 808 / 966 | 98% | 34.45 | 515 / 527 |
bladder | 90% | 91.95 | 19 / 21 | 88% | 24.43 | 442 / 504 |
thymus | 94% | 107.85 | 613 / 653 | 79% | 17.97 | 476 / 605 |
uterus | 79% | 64.69 | 134 / 170 | 92% | 33.66 | 424 / 459 |
stomach | 65% | 56.42 | 232 / 359 | 97% | 36.89 | 278 / 286 |
kidney | 79% | 70.63 | 70 / 89 | 81% | 13.32 | 734 / 901 |
ovary | 55% | 39.21 | 99 / 180 | 95% | 20.85 | 407 / 430 |
pancreas | 55% | 39.23 | 181 / 328 | 93% | 34.66 | 166 / 178 |
prostate | 91% | 99.94 | 223 / 245 | 43% | 4.61 | 217 / 502 |
adrenal gland | 86% | 87.44 | 223 / 258 | 23% | 2.81 | 53 / 230 |
ureter | 0% | 0 | 0 / 0 | 100% | 14.32 | 1 / 1 |
adipose | 100% | 228.54 | 1203 / 1204 | 0% | 0 | 0 / 0 |
blood vessel | 99% | 157.85 | 1322 / 1335 | 0% | 0 | 0 / 0 |
tonsil | 0% | 0 | 0 / 0 | 98% | 40.04 | 44 / 45 |
eye | 0% | 0 | 0 / 0 | 84% | 11.04 | 67 / 80 |
spleen | 79% | 58.29 | 191 / 241 | 0% | 0 | 0 / 0 |
heart | 70% | 58.85 | 603 / 861 | 0% | 0 | 0 / 0 |
liver | 21% | 14.44 | 47 / 226 | 45% | 7.57 | 181 / 406 |
peripheral blood | 61% | 47.47 | 564 / 929 | 0% | 0 | 0 / 0 |
muscle | 58% | 47.41 | 468 / 803 | 0% | 0 | 0 / 0 |
lymph node | 0% | 0 | 0 / 0 | 55% | 5.67 | 16 / 29 |
brain | 6% | 3.59 | 160 / 2642 | 31% | 10.36 | 220 / 705 |
abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
GO_1905602 | Biological process | positive regulation of receptor-mediated endocytosis involved in cholesterol transport |
GO_0042470 | Cellular component | melanosome |
GO_0005604 | Cellular component | basement membrane |
GO_0070062 | Cellular component | extracellular exosome |
GO_0005886 | Cellular component | plasma membrane |
GO_0012506 | Cellular component | vesicle membrane |
GO_0005737 | Cellular component | cytoplasm |
GO_0005634 | Cellular component | nucleus |
GO_0004859 | Molecular function | phospholipase inhibitor activity |
GO_0005509 | Molecular function | calcium ion binding |
GO_0008092 | Molecular function | cytoskeletal protein binding |
GO_0001786 | Molecular function | phosphatidylserine binding |
GO_0005544 | Molecular function | calcium-dependent phospholipid binding |
Gene name | ANXA2P2 |
Protein name | Putative annexin A2-like protein (Annexin A2 pseudogene 2) (Lipocortin II pseudogene) |
Synonyms | ANX2L2 ANX2P2 LPC2B |
Description | FUNCTION: Calcium-regulated membrane-binding protein whose affinity for calcium is greatly enhanced by anionic phospholipids. It binds two calcium ions with high affinity. May be involved in heat-stress response. . |
Accessions | A6NMY6 |